Inventor profile of:

Daniel Deaver

City:

Franklin, Massachusetts

Country:

United States

Published Applications:

26

Last publication date:

2019-06-27

Top Assignees for applications by Daniel Deaver

The entities that hold a legal rights for patent applications filed by inventor Deaver Daniel:

Recent patent applications by Deaver Daniel

Daniel Deaver from Franklin, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-06-27
US20190192505A1
Human necessities

Opioid agonist antagonist combinations

#2 | 2018-09-27
US20180271855A1
Human necessities

Methods for treating antipsychotic-induced weight gain

#3 | 2018-03-22
US20180078543A1
Human necessities

Compositions of buprenorphine and μ antagonists

#4 | 2018-03-22
US20180078542A1
Human necessities

Compositions of buprenorphine and μ antagonists

#5 | 2017-05-18
US20170136004A1
Human necessities

Opioid agonist antagonist combinations

#6 | 2017-05-04
US20170119757A1
Human necessities

Methods for treating antipsychotic-induced weight gain

#7 | 2017-04-27
US20170112827A1
Human necessities

Morphinan Derivatives with High Oral Bioavailability

#8 | 2017-03-02
US20170056392A1
Human necessities

Compositions of buprenorphine and μ antagonists

#9 | 2017-02-16
US20170042882A1
Human necessities

Selective Opioid Compounds

#10 | 2016-09-08
US20160256450A1
Human necessities

Compositions of buprenorphine and μ antagonists

#11 | 2016-08-25
US20160243112A1
Human necessities

TREATMENTS FOR ALZHEIMER'S RELATED DISEASES AND DISORDERS

#12 | 2016-03-24
US20160082004A1
Human necessities

Selective Opioid Compounds

#13 | 2016-02-25
US20160051538A1
Human necessities

Methods for treating antipsychotic-induced weight gain

#14 | 2015-04-02
US20150094325A1
Chemistry; metallurgy

Morphinan Derivatives with High Oral Bioavailability

#15 | 2015-02-19
US20150051240A1
Human necessities

Compositions of buprenorphine and μ Antagonists

#16 | 2014-11-27
US20140349999A1
Chemistry; metallurgy

Methods for treating antipsychotic-induced weight gain

#17 | 2014-01-02
US20140005215A1
Chemistry; metallurgy

Selective opioid compounds

#18 | 2013-10-24
US20130281388A1
Human necessities

Opioid agonist antagonist combinations

#19 | 2013-07-25
US20130190342A1
Human necessities

Compositions of buprenorphine and μ antagonists

#20 | 2012-09-27
US20120245193A1
Human necessities

PERIPHERIALLY ACTING μ OPIOID ANTAGONISTS

#21 | 2012-03-29
US20120077800A1
Human necessities

Methods for treating antipsychotic-induced weight gain

#22 | 2010-09-23
US20100240691A1
Human necessities

MORPHINAN DERIVATIVES WITH HIGH ORAL BIOAVAILABILITY

#23 | 2009-08-20
US20090209569A1
Human necessities

Selective opioid compounds

#24 | 2007-05-03
US20070099947A1
Human necessities

Methods and compositions for the treatment of brain reward system disorders by combination therapy

#25 | 2007-02-22
US20070041912A1
Human necessities

Trospium containing compositions

#26 | 2006-06-22
US20060134009A1
Human necessities

Low dose corticosteroid powders for inhalation

InventorID:

355689 ⎘